• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Promising new agents for treatment of patients with colorectal cancer.

作者信息

Von Hoff D D

机构信息

Institute for Drug Development, Department of Medicine, The University of Texas Health Science Center at San Antonio, 78245, USA.

出版信息

Semin Oncol. 1998 Oct;25(5 Suppl 11):47-52.

PMID:9786316
Abstract

Colorectal cancer continues to be a major problem. There are a number of new agents with promising clinical activity, including the multitargeted antifolate LY 231514 and the thymidylate synthesis inhibitor capecitabine. In addition, other agents have shown promising preclinical activity against the disease: 6-hydroxymethylacylfulvene (HMAF; MGI 114), LY 295501, bizelesin (U-7779; NSC615291), and ONYX-015. Finally, several agents may prevent colorectal cancer through prevention of the formation of colorectal polyps (eg, cyclooxygenase inhibitors).

摘要

相似文献

1
Promising new agents for treatment of patients with colorectal cancer.
Semin Oncol. 1998 Oct;25(5 Suppl 11):47-52.
2
The use of thymidylate synthase inhibitors in the treatment of advanced colorectal cancer: current status.胸苷酸合成酶抑制剂在晚期结直肠癌治疗中的应用：现状
Oncologist. 1999;4(6):478-87.
3
Novel therapeutic developments other than EGFR and VEGF inhibition in colorectal cancer.除表皮生长因子受体（EGFR）和血管内皮生长因子（VEGF）抑制之外的结直肠癌新型治疗进展。
Oncologist. 2006 Oct;11(9):1018-24. doi: 10.1634/theoncologist.11-9-1018.
4
Thymidylate synthase inhibitors in colorectal cancer.
Semin Oncol. 2000 Oct;27(5 Suppl 10):83-7.
5
The use of thymidylate synthase inhibitors in the treatment of advanced colorectal cancer: current status.胸苷酸合成酶抑制剂在晚期结直肠癌治疗中的应用：现状
Stem Cells. 2000;18(3):166-75. doi: 10.1634/stemcells.18-3-166.
6
Thymidylate synthase inhibitors as anticancer agents: from bench to bedside.胸苷酸合成酶抑制剂作为抗癌药物：从实验室到临床应用
Cancer Chemother Pharmacol. 2003 Jul;52 Suppl 1:S80-9. doi: 10.1007/s00280-003-0625-9. Epub 2003 Jun 18.
7
Thymidylate synthase inhibitors.
Cancer Chemother Biol Response Modif. 2001;19:1-19.
8
Novel therapeutic strategies for colorectal cancer.结直肠癌的新型治疗策略。
Hosp Med. 1998 Aug;59(8):617-21.
9
Thymidylate synthase level as the main predictive parameter for sensitivity to 5-fluorouracil, but not for folate-based thymidylate synthase inhibitors, in 13 nonselected colon cancer cell lines.在13个未经筛选的结肠癌细胞系中，胸苷酸合成酶水平作为对5-氟尿嘧啶敏感性的主要预测参数，但对基于叶酸的胸苷酸合成酶抑制剂则不然。
Clin Cancer Res. 1999 Mar;5(3):643-54.
10
[Oxaliplatin: perspectives and future developments].
Bull Cancer. 2001 Aug;88 Spec No:S5-8.

引用本文的文献

1
Role of caspases in 5-FU and selenium-induced growth inhibition of colorectal cancer cells.半胱天冬酶在5-氟尿嘧啶和硒诱导的结肠癌细胞生长抑制中的作用。
Anticancer Res. 2008 Nov-Dec;28(6A):3579-92.
2
Chemo-immunotherapy of colorectal carcinoma: preclinical rationale and clinical experience.结直肠癌的化学免疫疗法：临床前理论依据与临床经验
Invest New Drugs. 2006 Mar;24(2):99-110. doi: 10.1007/s10637-006-5932-7.
3
A novel biweekly multidrug regimen of gemcitabine, oxaliplatin, 5-fluorouracil (5-FU), and folinic acid (FA) in pretreated patients with advanced colorectal carcinoma.
一种用于晚期结直肠癌预处理患者的新型双周多药方案，包含吉西他滨、奥沙利铂、5-氟尿嘧啶（5-FU）和亚叶酸（FA）。
Br J Cancer. 2004 May 4;90(9):1710-4. doi: 10.1038/sj.bjc.6601783.